Business · 23/05/1994Updated: 10/16/2026 · 1 min read
Fujisawa USA, Inc., et al.; Withdrawal of Approval of 22 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 22 abbreviated new drug applications (ANDA's) as the holders of the ANDA's notified the agency that the drug products were no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →